Conventional radiography and correlated factors of enthesopathies of the Achilles tendon and plantar fascia in patients with axial spondyloarthritis

Ebru Yılmaz; Özge Pasin; Loiane Cristina de Souza; Guilherme Torres Vilarino; Alexandro Andrade; Camila Gusmão Vicente de Carvalho; Barbara Bayeh; Fernando Henrique Carlos de Souza; Renata Miossi; Pleiades Tiharu Inaoka; Takashi Matsushita; Naoki Mugii; Samuel Katsuyuki Shinjo

doi:10.4081/reumatismo.2024.1709

Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients

M. Romano, I. Pontikaki, M. Gattinara, I. Ardoino, C. Donati, P. Boracchi, P.L. Meroni, V. Gerloni

278-285

17-03-2014

https://doi.org/10.4081/reumatismo.2013.682

2632

PDF: 1361
Are biological drugs safe in pregnancy?

A. Calligaro, A. Hoxha, A. Ruffatti, L. Punzi

304-317

31-03-2015

https://doi.org/10.4081/reumatismo.2014.798

3723

PDF: 2400
On the history of biological drugs: the true discovery of the IL-1 receptor antagonist

L. Punzi, P. Marson

180

19-07-2012

https://doi.org/10.4081/reumatismo.2012.180

765

PDF (Italian): 396
Possible relationship between certolizumab pegol and arrhythmias: report of two cases

R. Talotta, F. Atzeni, A. Batticciotto, D. Ventura, P. Sarzi-Puttini

104-108

09-09-2016

https://doi.org/10.4081/reumatismo.2016.869

1556

PDF: 947
The impact on disability of initial treatment with methotrexate in patients with rheumatoid arthritis: results from the MARI study

M. Manara, L. Arcarese, G. Bianchi, V. Corbelli, O. Epis, R. Laurenti, A. Migliore, M. Muratore, A. Roncaglione, M. Rossini, M. Savo, L. Sinigaglia

188-194

31-12-2016

https://doi.org/10.4081/reumatismo.2016.903

1744

PDF: 918
IgA deficiency evidence after anti-TNF-α treatment in a psoriatic arthritis patient: case report

S. Iervolino, M. Lofrano, M.N.D. Di Minno, F. Foglia, R. Scarpa, R. Peluso

40-43

19-03-2012

https://doi.org/10.4081/reumatismo.2012.40

958

PDF: 1525
A short history of anti-rheumatic therapy - VII. Biological agents

G. Pasero, P. Marson, B. Gatto

185-194

09-11-2011

https://doi.org/10.4081/reumatismo.2011.185

1487

PDF: 1220
Anti-TNFα agents in elderly patients with rheumatoid arthritis: a study of a group of 105 over sixty five years old patients

M. Filippini, C. Bazzani, S. Zingarelli, T. Ziglioli, M. Nuzzo, M. Vianelli, C. Biasini Rebaioli, R. Cattaneo, R. Gorla

41-49

https://doi.org/10.4081/reumatismo.2008.41

1160

PDF: 774
Retention rate of tumor necrosis factor inhibitors, anti-interleukin 17, and anti-interleukin 12/23 drugs in a single-center cohort of psoriatic arthritis patients

M. Ferrito, G. Cincinelli, M. Manara, R. Di Taranto, E.G. Favalli, R. Caporali

17-07-2023

https://doi.org/10.4081/reumatismo.2023.1544

1001

PDF: 544
The bisphosponates: chemical characteristics, skeletal biological effects and extra-skeletal effects

A. Corrado, F.P. Cantatore

142-153

11-04-2005

https://doi.org/10.4081/reumatismo.2005.142

881

PDF: 1890
Socio-demographic aspects and therapeutic pathways in patients with rheumatoid arthritis in Italy

F. Salaffi, C.M. Vaccaro, T. Manacorda, L. Pardini, C.M. Montecucco

197-211

https://doi.org/10.4081/reumatismo.2009.197

1169

PDF: 896
Real-world clinical experience with secukinumab in psoriatic arthritis: an observational study and a literature review

Eleonora Celletti, Giulio Gualdi, Emanuela Sabatini, Francesco Cipollone, Fabio Lobefaro, Paolo Amerio

27-01-2025

https://doi.org/10.4081/reumatismo.2025.1694

1576

PDF: 19
Pregnancy in patients affected by axial-spondyloarthritis: a narrative review of disease activity and obstetric outcomes

M. Filippini, G. Fontana, P. Bizioli, F. Crisafulli, R. Orabona, S. Zatti, F. Franceschini, A. Tincani

11-09-2024

https://doi.org/10.4081/reumatismo.2024.1697

906

PDF: 379
Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)

P. Sarzi- Puttini, M. Antivalle, A. Marchesoni, E.G. Favalli, R. Gorla, M. Filippini, R. Caporali, F. Bobbio-Pallavicini, C. Montecucco, F. Atzeni

290-295

https://doi.org/10.4081/reumatismo.2008.290

2056

PDF: 1058
On the main stages of the history of intra-articular therapy

P. Marson, G. Pasero, L. Punzi, G. Zanchin

262-268

https://doi.org/10.4081/reumatismo.2007.262

1357

PDF: 1114
MonitorNet: studio italiano osservazionale multicentrico per la valutazione del profilo rischio-beneficio dei farmaci biologici nella pratica clinica reumatologica

P. Sfriso, F. Salaffi, C.M. Montecucco, S. Bombardieri, S. Todesco

132-139

https://doi.org/10.4081/reumatismo.2009.132

1902

PDF: 1128
The Italian Society of Rheumatology clinical practice guidelines for the management of large vessel vasculitis

N. Ughi, R. Padoan, C. Crotti, S. Sciascia, G. Carrara, A. Zanetti, D. Rozza, S. Monti, D. Camellino, F. Muratore, G. Emmi, L. Quartuccio, S. Morbelli, K. El Aoufy, S. Tonolo, R. Caporali, S. De Vita, C. Salvarani, M.A. Cimmino

07-02-2022

https://doi.org/10.4081/reumatismo.2021.1470

9294

PDF: 2045
COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?

Z. Ahmadinejad, R. Assari, N. Ayoobi Yazdi, S.-H. Mazloomi, P. Javanshayani, H. Khalili Afousi, V. Ziaee

173-177

19-11-2020

https://doi.org/10.4081/reumatismo.2020.1289

1604

PDF: 994
Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvement

G. Adami, L. Idolazzi, C. Benini, E. Fracassi, A. Carletto, O. Viapiana, D. Gatti, M. Rossini, A. Fassio

08-05-2023

https://doi.org/10.4081/reumatismo.2023.1559

1582

PDF: 872
Safety of anti-TNFa biological drugs

F. Trotta, G. Valentini

34-39

https://doi.org/10.4081/reumatismo.2005.4s.34

1131

PDF: 1125
Severe Behçet’s disease equally affects both genders in Egyptian patients: A multicentre retrospective follow-up study

D.H.S. Attia, R.A. Abdel Noor

218-225

28-01-2020

https://doi.org/10.4081/reumatismo.2019.1223

1303

PDF: 750
Are there differences among anti-TNFa biological drugs?

G. Valesini

1-2

https://doi.org/10.4081/reumatismo.2005.4s.1

747

PDF: 582
Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases

S. Zingarelli, P. Airò, M. Frassi, C. Bazzani, M. Scarsi, M. Puoti

22-27

https://doi.org/10.4081/reumatismo.2008.22

1154

PDF: 945
The Italian Society for Rheumatology guidelines on reproductive health in patients with rheumatic diseases

Chiara Crotti, Nicola Ughi, Emanuela Beretta, Antonio Luca Brucato, Greta Carrara, Maria Sole Chimenti, Paola Conigliaro, Francesca Crisafulli, Giovanna Cuomo, Emma Di Poi, Khadija El Auofy, Micaela Fredi, Maria Chiara Gerardi, Maria Gerosa, Ariela Hoxa, Aurora Ianniello, Maddalena Larosa, Danila Morano, Marta Mosca, Mario Motta, Martina Orlandi, Melissa Padovan, Davide Rozza, Savino Sciascia, Silvia Tonolo, Simona Truglia, Maria Letizia Urban, Anna Zanetti, Sonia Zatti, Angela Tincani

12-02-2025

https://doi.org/10.4081/reumatismo.2025.1752

1683

PDF: 451

SUPPLEMENTARY MATERIAL: 155
Neprhrotic syndrome in a patient with rheumatoid arthritis treated with adalimumab: a case report

M.G. Portuesi, P. Perosa

61-63

https://doi.org/10.4081/reumatismo.2008.61

1153

PDF: 863

1 - 25 of 25 items

Search

Search Results

Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients

Are biological drugs safe in pregnancy?

On the history of biological drugs: the true discovery of the IL-1 receptor antagonist

Possible relationship between certolizumab pegol and arrhythmias: report of two cases

The impact on disability of initial treatment with methotrexate in patients with rheumatoid arthritis: results from the MARI study

IgA deficiency evidence after anti-TNF-α treatment in a psoriatic arthritis patient: case report

A short history of anti-rheumatic therapy - VII. Biological agents

Anti-TNFα agents in elderly patients with rheumatoid arthritis: a study of a group of 105 over sixty five years old patients

Retention rate of tumor necrosis factor inhibitors, anti-interleukin 17, and anti-interleukin 12/23 drugs in a single-center cohort of psoriatic arthritis patients

The bisphosponates: chemical characteristics, skeletal biological effects and extra-skeletal effects

Socio-demographic aspects and therapeutic pathways in patients with rheumatoid arthritis in Italy

Real-world clinical experience with secukinumab in psoriatic arthritis: an observational study and a literature review

Pregnancy in patients affected by axial-spondyloarthritis: a narrative review of disease activity and obstetric outcomes

Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)

On the main stages of the history of intra-articular therapy

MonitorNet: studio italiano osservazionale multicentrico per la valutazione del profilo rischio-beneficio dei farmaci biologici nella pratica clinica reumatologica

The Italian Society of Rheumatology clinical practice guidelines for the management of large vessel vasculitis

COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?

Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvement

Safety of anti-TNFa biological drugs

Severe Behçet’s disease equally affects both genders in Egyptian patients: A multicentre retrospective follow-up study

Are there differences among anti-TNFa biological drugs?

Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases

The Italian Society for Rheumatology guidelines on reproductive health in patients with rheumatic diseases

Neprhrotic syndrome in a patient with rheumatoid arthritis treated with adalimumab: a case report

authors

reviewers

Categories

indexing

Keywords